Pharmaceutical policy in the UK involves a trade-off between the interest of the National HealthService in controlling expenditure on drugs and the interest of the pharmaceutical industry inproviding an incentive for research and development. Since 1957, the Pharmaceutical PriceRegulation Scheme...

Trade liberalisation is a driver of the rising burden of non-communicable diseases in Asia through its role in facilitating the growth of the region's tobacco, alcohol and ultra-processed foods industries while simultaneously restricting the capacities of governments to enact public health...